MMizuho RRivian · RIVN

Mizuho Downgrades Rivian to ‘Underperform,’ Cuts PT to $10

Oct 20, 2025· 1 min read· Reproduced verbatim
Rating
Sell
Price target
$10
Previous
$14
Implied downside
-23%

Mizuho analyst Vijay Rakesh downgraded on October 20, 2025, Rivian’s rating from ‘Neutral’ to ‘Underperform,’ while lowering the price target to $10 (from $14).

“Downgrading RIVN to Underperform on SOFTER 2026 EV Sales Outlook as IRA Credits End.

We lower our 2026E RIVN deliveries to 60k units from 68k previously (consensus 72k), now up ~40% y/y (still challenging) vs. consensus +69% y/y, as we see BEV demand soften.

N.Am EV LVP [North American Electric Vehicle Light Vehicle Production] is expected FLAT y/y, with General Motors (GM) recorded a $1.6B SepQ EV impairment charge (Link), signaling broader EV weakness.

IRA credits ending in the US is an added headwind as 3Q25 volumes were 13k, up 25% q/q, but with elevated ASPs (>$70k), near-term deliveries could struggle ahead of its expected R2 launch in 1H26E.

We are downgrading RIVN to Underperform, lowering estimates ~13% below consensus and PT to $10 $14 as US BEV Demand faces headwinds.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.